Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non-small cell lung cancer from proteomic profiling of circulating extracellular vesicles.
Autorzy:
Torasawa M; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Horinouchi H; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. Yagishita S; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tokyo, Japan. Utsumi H; Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan. Okuda K; Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan. Takekoshi D; Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan. Ito S; Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan. WakuiH; Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan. Murata S; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. Kaku S; Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan. Okuma K; Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan. Matsumoto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. Shinno Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. Okuma Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. Yoshida T; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan. Goto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. Yamamoto N; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan. Araya J; Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan. Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. Fujita Y; Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.; Division of Next-Generation Drug Development Research, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Oct; Vol. 14 (29), pp. 2909-2923. Date of Electronic Publication: 2023 Aug 24.
Author Correction: Angiotensin II type-1 receptor-associated protein interacts with transferrin receptor-1 and promotes its internalization.
Autorzy:
Abe E; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Department of Molecular Biology, Yokohama City University Graduate School of Medicine, Yokohama, Japan. Yamashita A; Department of Investigative Medicine Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan. . Hirota K; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. Yamaji T; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, Singapore, Singapore. Azushima K; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. Urate S; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. Suzuki T; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. Tanaka S; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. Taguchi S; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. Tsukamoto S; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. Uehara T; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. WakuiH; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. . Tamura K; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. Takahashi H; Department of Molecular Biology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Dec 09; Vol. 12 (1), pp. 21322. Date of Electronic Publication: 2022 Dec 09.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
